Jinsei Maruyama - Taisho Pharmaceutical Co Officer

Insider

Jinsei Maruyama is Co Officer of Taisho Pharmaceutical Holdings
Phone81 3 3985 2020
Webhttps://www.taisho-holdings.co.jp

Taisho Pharmaceutical Management Efficiency

The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Tamara RogersHaleon plc
55
Melissa TrombettaViatris
N/A
MS BTechDr Reddys Laboratories
58
Galia InbarTeva Pharma Industries
N/A
R HooverElanco Animal Health
75
Yoshimasa KyokawaShionogi Co
N/A
Mairead NayagerHaleon plc
49
Deepak MBADr Reddys Laboratories
50
Scott FergusonElanco Animal Health
46
Robert SrEmergent Biosolutions
67
Brian RomanViatris
55
Ellen BrabanderElanco Animal Health
62
Eli ShaniTeva Pharma Industries
N/A
ACGI BScHUTCHMED DRC
70
Jooyong LeeHaleon plc
47
Andrew WeilTeva Pharma Industries
52
Erez MBADr Reddys Laboratories
57
K SinghDr Reddys Laboratories
N/A
Dirk EhleElanco Animal Health
50
Roy MDPacira BioSciences,
62
Susumu MitsumoriShionogi Co
N/A
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people. Taisho Pharmaceutical Holdings [TAIPY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Taisho Pharmaceutical Leadership Team

Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director
Shinichi Tanaka, Gen Communications
Akira Uehara, President Chairman of Subsidiary, Representative Director
Jinsei Maruyama, Co Officer
Tetsu Watanabe, Executive Director
Jun Kuroda, Ex Director
Ken Uehara, MD Director
Hideki Iuchi, G Mang
Hisashi Umeoka, Director

Taisho Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Taisho Pink Sheet

If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data